scholarly journals Hybrid Nanoparticle Platform for Nanoscale Scintillation Proximity Assay

2019 ◽  
Vol 2 (3) ◽  
pp. 1259-1266
Author(s):  
Colleen M. Janczak ◽  
Isen A.C. Calderon ◽  
Eka Noviana ◽  
Priyanka Hadvani ◽  
Joo Ryung Lee ◽  
...  

2020 ◽  
Vol 5 (8) ◽  
pp. 1428-1436
Author(s):  
Anu Saini ◽  
Manpreet Kaur ◽  
Mayank ◽  
Anil Kuwar ◽  
Navneet Kaur ◽  
...  

Hybrid nanoassembly, fluorescent chemosensors, selective response to ketoprofen, and nanomolar detection.



2021 ◽  
Vol 19 (1) ◽  
Author(s):  
Federica Palombarini ◽  
Silvia Masciarelli ◽  
Alessio Incocciati ◽  
Francesca Liccardo ◽  
Elisa Di Fabio ◽  
...  

Abstract Background In recent years, the use of ferritins as nano-vehicles for drug delivery is taking center stage. Compared to other similar nanocarriers, Archaeoglobus fulgidus ferritin is particularly interesting due to its unique ability to assemble-disassemble under very mild conditions. Recently this ferritin was engineered to get a chimeric protein targeted to human CD71 receptor, typically overexpressed in cancer cells. Results Archaeoglobus fulgidus chimeric ferritin was used to generate a self-assembling hybrid nanoparticle hosting an aminic dendrimer together with a small nucleic acid. The positively charged dendrimer can indeed establish electrostatic interactions with the chimeric ferritin internal surface, allowing the formation of a protein-dendrimer binary system. The 4 large triangular openings on the ferritin shell represent a gate for negatively charged small RNAs, which access the internal cavity attracted by the dense positive charge of the dendrimer. This ternary protein-dendrimer-RNA system is efficiently uptaken by acute myeloid leukemia cells, typically difficult to transfect. As a proof of concept, we used a microRNA whose cellular delivery and induced phenotypic effects can be easily detected. In this article we have demonstrated that this hybrid nanoparticle successfully delivers a pre-miRNA to leukemia cells. Once delivered, the nucleic acid is released into the cytosol and processed to mature miRNA, thus eliciting phenotypic effects and morphological changes similar to the initial stages of granulocyte differentiation. Conclusion The results here presented pave the way for the design of a new family of protein-based transfecting agents that can specifically target a wide range of diseased cells. Graphic abstract



2021 ◽  
Vol 62 ◽  
pp. 378-387
Author(s):  
Vaibhav Singh ◽  
Anuj Kumar Sharma ◽  
Ranjeet Kumar Sahu ◽  
Jitendra Kumar Katiyar


2021 ◽  
Vol 42 (3) ◽  
pp. 347-356
Author(s):  
S. A. Shehzad ◽  
M. Sheikholeslami ◽  
T. Ambreen ◽  
A. Saleem ◽  
A. Shafee


1997 ◽  
Vol 38 (11) ◽  
pp. 2365-2373
Author(s):  
J C Hanselman ◽  
D A Schwab ◽  
T J Rea ◽  
C L Bisgaier ◽  
M E Pape


2017 ◽  
Vol 533 (1) ◽  
pp. 73-83 ◽  
Author(s):  
Jie Hou ◽  
Chunlei Guo ◽  
Yuzhi Shi ◽  
Ergang Liu ◽  
Weibing Dong ◽  
...  




1994 ◽  
Vol 31 (3) ◽  
pp. 103 ◽  
Author(s):  
Susan Fenwick ◽  
William N. Jenner ◽  
Paul Linacre ◽  
Regina M. Rooney ◽  
Stephen A. Wring


Author(s):  
Snigdharani Panda ◽  
Chandra Sekhar Bhol ◽  
Sujit Kumar Bhutia ◽  
Sasmita Mohapatra

A hybrid nanoparticle consisting of N-doped mesoporous carbon nanospheres as core and thermosensitive PEG–PEI as outer shell shows multiple therapeutic actions such as PTT, PDT and NIR sensitive drug release under single 980 nm laser excitation.



Author(s):  
Randall A. Meyer ◽  
G. Patrick Hussmann ◽  
Norman C. Peterson ◽  
Jose Luis Santos ◽  
Anthony D. Tuesca


Sign in / Sign up

Export Citation Format

Share Document